# OpenEvidence valued at $15 billion in new funding round

Digest AI · Business & Funding · published 2026-09-23T21:36:00Z

Canonical: https://digestai.news/story/openevidence-valued-at-15-billion-in-new-funding-round

## Summary

OpenEvidence, an AI search engine designed for medical professionals, has secured a new funding round that values the company at $15 billion. The startup recently raised $250 million from hospital systems and Andreessen Horowitz, according to people familiar with the matter. This follows a January round that valued the company at $12 billion, bringing its total funding over the past year to more than $1 billion from investors including Thrive Capital, DST, GV, Kleiner Perkins, and Sequoia Capital.

The company, based in Miami, claims its product is the fastest-growing application for physicians in history, with more than two-thirds of U.S. doctors using it for diagnostic and treatment advice. OpenEvidence maintains relationships with major tech firms, including Nvidia as an investor, and recently announced a partnership with Anthropic. It also integrates with AI tools from Google and Microsoft.

Sources indicate OpenEvidence may be open to a merger or acquisition deal that includes access to compute resources, a potential strategy if rising anti-AI sentiment limits data center expansion. However, it is unverified if specific acquirers are interested, and the company may prefer to remain independent. This funding comes as AI giants like OpenAI and Anthropic increasingly build their own healthcare tools, making OpenEvidence a potential shortcut for acquiring established user bases and medical data expertise.

## Key points

- OpenEvidence raised $250 million, valuing the company at $15 billion.
- More than two-thirds of U.S. doctors use the AI search engine.
- The company may be open to an M&A deal involving compute access.

## Why it matters

OpenEvidence's rapid growth and high valuation signal strong adoption of AI in healthcare. Its potential acquisition interest highlights how major AI firms may buy established medical tools to secure user bases and data access.

## Sources

1. [The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round](https://businessinsider.com/chatgpt-for-medicine-openevidence-fielding-valuation-2026-9) (businessinsider.com, 2026-09-23)

Part of the developing story: [Anthropic and OpenEvidence Launch Global Medical AI](https://digestai.news/thread/anthropic-partners-with-openevidence-to-launch-ai-search-tool-for-physicians-in) (2 stories)

## Cite

Digest AI, "OpenEvidence valued at $15 billion in new funding round", 23 September 2026, https://digestai.news/story/openevidence-valued-at-15-billion-in-new-funding-round

---

Written by Digest AI's editorial model from the linked sources; the sources are the record. Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse
JSON: https://digestai.news/story/openevidence-valued-at-15-billion-in-new-funding-round.json